To assess the progression of multiple sclerosis using gait analysis with inertial sensors to find more objective, sensitive and reliable measures to detect and monitor the clinical progression of progressive Multiple Sclerosis. To validate selected measures provided by inertial sensors to monitor gait in a prospective cohort of patients with Multiple Sclerosis in early (primary and secondary) stages.

We are specially focused in the assessment of the efficacy and effectiveness of techniques such as Mindfulness and we evaluate hypothetical mediators of response, such as neurotrophic factors or factors related to inflammatory response.

Moreover, the group is involved in the evaluation of new treatments or new indications in mental disorders through the participation in clinical trials.